(6) Segments and Geographic Information

The Company and its subsidiaries currently operate in two segments, product and service. The product segment oversees the supply chain and manufacturing of Crinone, the Company’s sole commercialized product. The service segment includes product development, clinical trial manufacturing, and advanced analytical and consulting services for the Company’s customers as well as characterizing and developing pharmaceutical product candidates for the Company’s internal programs. The Company conducts its advanced formulation, analytical and consulting services through its subsidiary, Juniper Pharma Services, the Company’s U.K.-based provider of pharmaceutical development, clinical trial manufacturing and advanced analytical and consulting services to the pharmaceuticals industry. The Company has integrated its supply chain management for Crinone into those operations and has therefore sought to capture synergies by transferring all operational activities related to its historic business. The Company owns certain plant and equipment physically located at third-party contractor facilities in the United Kingdom (the “U.K.”) and Switzerland.

The Company’s largest customer, Merck KGaA, utilizes a Switzerland-based subsidiary to acquire product from the Company, which it then sells throughout the world, excluding the United States (the “U.S.”).

The following tables show selected information by geographic area (in thousands):

Revenues:

	Three Months Ended June 30,				Six Months Ended June 30,
	2018		2017		2018		2017
United States	$	3,917	$	2,387	$	7,459	$	4,015
Switzerland		9,518		9,759		19,796		17,516
United Kingdom		1,182		1,088		1,975		2,037
Other countries		693		722		1,604		1,635
Total	$	15,310	$	13,956	$	30,834	$	25,203

Total assets:

	June 30, 2018		December 31, 2017
United States	$	20,886	$	21,683
Switzerland		7,362		1,366
United Kingdom		39,491		38,129
Other countries		29		42
Total	$	67,768	$	61,220

Long-lived assets:

	June 30, 2018		December 31, 2017
United States	$	345	$	523
Switzerland		1,257		535
United Kingdom		16,129		15,064
Other countries		3		2
Total	$	17,734	$	16,124

Long-lived assets include fixed assets, intangibles and other assets.

No other individual country represented greater than 10% of total revenues, total assets or total long-lived assets for any period presented.

For the three and six months ended June 30, 2018 and 2017, Merck KGaA accounted for 100% of the product segment revenue. At June 30, 2018 and December 31, 2017, Merck KGaA made up 100% of the product segment accounts receivable.

For the three and six months ended June 30, 2018 and 2017, the same customer accounted for 41% and 28% and 37% and 23% of the service segment total revenue, respectively. No additional customers accounted for 10% or more of the service segment total revenue for the three or six months ended June 30, 2018 and 2017. At June 30, 2018 and December 31, 2017, one customer accounted for 47% and 53% of total service segment accounts receivable, respectively.

The following summarizes other information by segment for the three months ended June 30, 2018 (in thousands):

	Product		Service		Total
Revenues
Product revenues	$	9,343	$	—	$	9,343
Service revenues		—		5,717		5,717
License revenues		250		—		250
Total revenues	$	9,593	$	5,717	$	15,310
Cost of product revenues		6,158		—		6,158
Cost of service revenues		—		2,959		2,959
Total cost of revenues	$	6,158	$	2,959	$	9,117
Gross profit	$	3,435	$	2,758	$	6,193
Total operating expenses						8,136
Total non-operating income						729
Loss before income taxes					$	(1,214	)

The following summarizes other information by segment for the three months ended June 30, 2017 (in thousands):

	Product		Service		Total
Revenues
Product revenues	$	9,569	$	—	$	9,569
Service revenues		—		4,387		4,387
Total revenues	$	9,569	$	4,387	$	13,956
Cost of product revenues		5,303		—		5,303
Cost of service revenues		—		2,347		2,347
Total cost of revenues	$	5,303	$	2,347	$	7,650
Gross profit	$	4,266	$	2,040	$	6,306
Total operating expenses						6,662
Total non-operating expense						(20	)
Loss before income taxes					$	(376	)

The following summarizes other information by segment for the six months ended June 30, 2018 (in thousands):

	Product		Service		Total
Revenues
Product revenues	$	19,417	$	—	$	19,417
Service revenues		—		11,167		11,167
License revenues		250		—		250
Total revenues	$	19,667	$	11,167	$	30,834
Cost of product revenues		12,174		—	$	12,174
Cost of service revenues		—		5,969	$	5,969
Total cost of revenues	$	12,174	$	5,969		18,143
Gross profit	$	7,493	$	5,198	$	12,691
Total operating expenses						13,618
Total non-operating income						485
Loss before income taxes					$	(442	)

The following summarizes other information by segment for the six months ended June 30, 2017 (in thousands):

	Product		Service		Total
Revenues
Product revenues	$	17,295	$	—	$	17,295
Service revenues		—		7,908		7,908
Total revenues	$	17,295	$	7,908	$	25,203
Cost of product revenues	$	9,617	$	—	$	9,617
Cost of service revenues		—		4,590		4,590
Total cost of revenues	$	9,617	$	4,590	$	14,207
Gross profit	$	7,678	$	3,318	$	10,996
Total operating expenses						12,807
Total non-operating expense						(6	)
Loss before income taxes					$	(1,817	)